BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,967,780 | -22.4% | 2,853,634 | -4.4% | 0.00% | 0.0% |
| Q2 2023 | $3,822,268 | -3.1% | 2,986,147 | +5.2% | 0.00% | 0.0% |
| Q1 2023 | $3,945,439 | +10.3% | 2,838,445 | +3.1% | 0.00% | 0.0% |
| Q4 2022 | $3,577,810 | -12.2% | 2,752,162 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,073,000 | -27.5% | 2,752,048 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $5,621,000 | -25.5% | 2,755,326 | +0.1% | 0.00% | -50.0% |
| Q1 2022 | $7,541,000 | -45.3% | 2,752,156 | -2.1% | 0.00% | -33.3% |
| Q4 2021 | $13,781,000 | -62.2% | 2,812,359 | -2.3% | 0.00% | -62.5% |
| Q3 2021 | $36,429,000 | -18.8% | 2,879,713 | -2.7% | 0.01% | -20.0% |
| Q2 2021 | $44,856,000 | -53.4% | 2,960,154 | +1.3% | 0.01% | -58.3% |
| Q1 2021 | $96,209,000 | – | 2,923,397 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |